Alterity Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Alterity Therapeutics (ATHE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Alterity Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Alterity Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alterity Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $27 | 5 | 5.40 |
| 2025-03-31 | $45k | 13k | 3.45 |
| 2024-12-31 | $1.3k | 384 | 3.31 |
| 2024-09-30 | $19k | 13k | 1.50 |
| 2024-06-30 | $4 | 2 | 2.00 |
| 2024-03-31 | $4 | 2 | 2.00 |
| 2023-09-30 | $314 | 127 | 2.48 |